Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Tamoxifen Market by Type (Tables, Capsules), By Application (Breast Cancer, Ovarian Cancer, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Tamoxifen Market by Type (Tables, Capsules), By Application (Breast Cancer, Ovarian Cancer, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137172 3300 Machinery & Equipment 377 241 Pages 4.7 (49)

Market Overview:

The global tamoxifen market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. Tamoxifen is a drug used for the treatment of breast cancer and ovarian cancer. It belongs to the class of drugs known as selective estrogen receptor modulators (SERMs). The growth in this market can be attributed to factors such as rising incidence of breast and ovarian cancers, increasing awareness about tamoxifen, and growing demand for targeted therapies. However, patent expirations of key products in this market are likely to restrain its growth over the forecast period. The global tamoxifen market can be segmented on the basis of type into tables and capsules. On the basis of application, it can be divided into breast cancer, ovarian cancer, and other applications. Geographically, it can be segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .

Global Tamoxifen Industry Outlook

Product Definition:

A medication used to treat breast cancer. Tamoxifen is a type of hormone therapy that works by blocking the effects of estrogen in the body.


Tables is a database management system that provides organization, integrity, and security to data. It offers features such as record locking, multiversion concurrency control, transaction logging etc. tables helps in storing information in the form of records that can be retrieved later on when needed.


Capsules are small containers made up of gelatin, which is an animal by-product. It is used to contain drugs and help it in protecting the drug molecules for a longer period of time. Capsules also provide the required amount of moisture so that the drugs can be easily administered with ease. The major function performed by capsules includes protection from stomach acids and enzymes as well as providing delayed-release mechanism to allow extended action over a specific period of time.

Application Insights:

Breast cancer accounted for the largest revenue share of over 40% in 2017. Breast cancer is one of the most common types of cancers diagnosed among women aged 50 years and above. According to data published by WHO, it has been estimated that around 1 in 8 breast carcinoma cases occur globally. The high prevalence coupled with rising awareness about early detection is expected to fuel market growth during the forecast period.

Ovarian cancer accounted for a significant revenue share owing to increasing incidence rates and awareness regarding early detection among women aged 35 years and above.

Regional Analysis:

North America was the largest revenue-generating region in 2017. The regional market is expected to grow at a CAGR of XX% during the forecast period. This growth can be attributed to various factors such as high awareness about tamoxifen and its benefits, presence of key manufacturers, and increasing incidence rates of breast cancer & ovarian cancer in U.S., which has led to an increase in demand for anti-cancer drugs like tamoxifen citrate tablets.

Asia Pacific is estimated to be one of the fastest growing regions during the same period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure & economic development in emerging countries like China.

Growth Factors:

  • Increasing incidence of breast cancer: The incidence of breast cancer is increasing at a rapid pace across the globe. This is expected to drive the demand for tamoxifen in the coming years.
  • Growing awareness about early detection and treatment options: There is a growing awareness among women about the importance of early detection and treatment options for breast cancer. This is likely to boost demand for tamoxifen in the near future.
  • Rising popularity of targeted therapies: The popularity of targeted therapies is rising rapidly, especially among patients with advanced-stage cancers. This is likely to create significant opportunities for tamoxifen in the coming years.

Scope Of The Report

Report Attributes

Report Details

Report Title

Tamoxifen Market Research Report

By Type

Tables, Capsules

By Application

Breast Cancer, Ovarian Cancer, Other

By Companies

AstraZeneca, Sanofi, Pfizer, Mylan , Wockhardt, Cipla, Actiza Pharmaceutical, Teva, Shanghai Forward Technology, Bayer, Liaoning Kangtai Pharmaceutical, Fu 'an Pharmaceutical Group, Yangtze River Pharmaceutical Group

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Tamoxifen Market Report Segments:

The global Tamoxifen market is segmented on the basis of:


Tables, Capsules

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Breast Cancer, Ovarian Cancer, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. AstraZeneca
  2. Sanofi
  3. Pfizer
  4. Mylan 
  5. Wockhardt
  6. Cipla
  7. Actiza Pharmaceutical
  8. Teva
  9. Shanghai Forward Technology
  10. Bayer
  11. Liaoning Kangtai Pharmaceutical
  12. Fu 'an Pharmaceutical Group
  13. Yangtze River Pharmaceutical Group

Global Tamoxifen Market Overview

Highlights of The Tamoxifen Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Tables
    2. Capsules
  1. By Application:

    1. Breast Cancer
    2. Ovarian Cancer
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Tamoxifen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Tamoxifen Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Tamoxifen is a medication used to treat breast cancer. It works by blocking the estrogen receptors in the body, which can help to reduce the growth of cancer cells. Tamoxifen may also help to prevent other types of cancers from developing in the future.

Some of the major companies in the tamoxifen market are AstraZeneca, Sanofi, Pfizer, Mylan‚ , Wockhardt, Cipla, Actiza Pharmaceutical, Teva, Shanghai Forward Technology, Bayer, Liaoning Kangtai Pharmaceutical, Fu 'an Pharmaceutical Group, Yangtze River Pharmaceutical Group.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Tamoxifen Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Tamoxifen Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Tamoxifen Market - Supply Chain
   4.5. Global Tamoxifen Market Forecast
      4.5.1. Tamoxifen Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Tamoxifen Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Tamoxifen Market Absolute $ Opportunity

5. Global Tamoxifen Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Tamoxifen Market Size and Volume Forecast by Type
      5.3.1. Tables
      5.3.2. Capsules
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Tamoxifen Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Tamoxifen Market Size and Volume Forecast by Application
      6.3.1. Breast Cancer
      6.3.2. Ovarian Cancer
      6.3.3. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Tamoxifen Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Tamoxifen Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Tamoxifen Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Tamoxifen Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Tamoxifen Demand Share Forecast, 2019-2029

9. North America Tamoxifen Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Tamoxifen Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Tamoxifen Market Size and Volume Forecast by Application
      9.4.1. Breast Cancer
      9.4.2. Ovarian Cancer
      9.4.3. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Tamoxifen Market Size and Volume Forecast by Type
      9.7.1. Tables
      9.7.2. Capsules
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Tamoxifen Demand Share Forecast, 2019-2029

10. Latin America Tamoxifen Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Tamoxifen Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Tamoxifen Market Size and Volume Forecast by Application
      10.4.1. Breast Cancer
      10.4.2. Ovarian Cancer
      10.4.3. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Tamoxifen Market Size and Volume Forecast by Type
      10.7.1. Tables
      10.7.2. Capsules
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Tamoxifen Demand Share Forecast, 2019-2029

11. Europe Tamoxifen Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Tamoxifen Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Tamoxifen Market Size and Volume Forecast by Application
      11.4.1. Breast Cancer
      11.4.2. Ovarian Cancer
      11.4.3. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Tamoxifen Market Size and Volume Forecast by Type
      11.7.1. Tables
      11.7.2. Capsules
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Tamoxifen Demand Share, 2019-2029

12. Asia Pacific Tamoxifen Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Tamoxifen Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Tamoxifen Market Size and Volume Forecast by Application
      12.4.1. Breast Cancer
      12.4.2. Ovarian Cancer
      12.4.3. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Tamoxifen Market Size and Volume Forecast by Type
      12.7.1. Tables
      12.7.2. Capsules
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Tamoxifen Demand Share, 2019-2029

13. Middle East & Africa Tamoxifen Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Tamoxifen Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Tamoxifen Market Size and Volume Forecast by Application
      13.4.1. Breast Cancer
      13.4.2. Ovarian Cancer
      13.4.3. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Tamoxifen Market Size and Volume Forecast by Type
      13.7.1. Tables
      13.7.2. Capsules
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Tamoxifen Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Tamoxifen Market: Market Share Analysis
   14.2. Tamoxifen Distributors and Customers
   14.3. Tamoxifen Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. AstraZeneca Overview Financials Developments Strategic Outlook
      14.4.2. Sanofi Overview Financials Developments Strategic Outlook
      14.4.3. Pfizer Overview Financials Developments Strategic Outlook
      14.4.4. Mylan  Overview Financials Developments Strategic Outlook
      14.4.5. Wockhardt Overview Financials Developments Strategic Outlook
      14.4.6. Cipla Overview Financials Developments Strategic Outlook
      14.4.7. Actiza Pharmaceutical Overview Financials Developments Strategic Outlook
      14.4.8. Teva Overview Financials Developments Strategic Outlook
      14.4.9. Shanghai Forward Technology Overview Financials Developments Strategic Outlook
      14.4.10. Bayer Overview Financials Developments Strategic Outlook
      14.4.11. Liaoning Kangtai Pharmaceutical Overview Financials Developments Strategic Outlook
      14.4.12. Fu 'an Pharmaceutical Group Overview Financials Developments Strategic Outlook
      14.4.13. Yangtze River Pharmaceutical Group Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us